Which events to consider in the study of venous thromboses in pancreatic cancer patients? Authors' reply

We appreciate the comments made by Debourdeau et al. [ [1] Debourdeau P. Launay S. Chaouche M. Which events to consider in the study of venous thromboses in pancreatic cancer patients?. Eur J Intern Med. 2022; S0953-6205 (00407-1)https://doi.org/10.1016/j.ejim.2022.11.017 Abstract Full Text Full Text PDF Scopus (1) Google Scholar ] regarding our recent publication “Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis” [ [2] García Adrián S. Rodríguez González A. Martínez de Castro E. Pachón Olmos V. Ortega Morán L. Martínez Del Prado P. et al. Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis. Eur J Intern Med. 2022; 105: 30-37https://doi.org/10.1016/j.ejim.2022.07.020 Abstract Full Text Full Text PDF PubMed Scopus (4) Google Scholar ].